Completed OBSERVATIONAL NCT03956836

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC) (HIPEC-COAG)

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Sponsor: Hospitales Universitarios Virgen del Rocío

Conditions Carcinomatosis Coagulation Disorder

Interventions ROTEM parameters, platelet function assay (PFA-100), von Willebrand and Factor XIII

Updated 8 times since 2019 Last updated: Mar 8, 2021 Started: Mar 27, 2020 Primary completion: Mar 8, 2021 Completion: Mar 8, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Carcinomatosis and Coagulation Disorder, this trial is completed. The trial is conducted by Hospitales Universitarios Virgen del Rocío and has accumulated 8 data snapshots since 2020. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Mar 2021 — Apr 2021 [monthly]

Recruiting

▶ Show 3 earlier versions

Jan 2021 — Mar 2021 [monthly]

Recruiting
Feb 2020 — Jan 2021 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting
Jun 2019 — Feb 2020 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospitales Universitarios Virgen del Rocío

Data source: Hospitales Universitarios Virgen del Rocío

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seville, Spain